GHRP-2 acetate (Growth Hormone Releasing Peptide-2 acetate salt) is a synthetic hexapeptide growth hormone secretagogue studied extensively in preclinical models for its selective activation of the ghrelin/growth hormone secretagogue receptor (GHS-R1a) to stimulate somatotroph signaling and endogenous growth hormone release in laboratory assays.
GHRP-2 acetate (Growth Hormone Releasing Peptide-2 acetate salt) is a synthetic hexapeptide growth hormone secretagogue studied extensively in preclinical models for its selective activation of the ghrelin/growth hormone secretagogue receptor (GHS-R1a) to stimulate somatotroph signaling and endogenous growth hormone release in laboratory assays.
GHRP-2 acetate, cataloged as D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 acetate salt, is a synthetic hexapeptide belonging to the class of growth hormone secretagogues (GHS). The peptide features unnatural D-amino acid substitutions (D-alanine, D-2-naphthylalanine, and D-phenylalanine) strategically positioned within its primary sequence. These chemical modifications confer enhanced enzymatic stability against circulating peptidases relative to native peptide ligands, allowing researchers to measure sustained receptor dynamics in vitro and in vivo models.
The acetate counterion salt form provides optimized aqueous solubility and physical stability compared to standard trifluoroacetate (TFA) salts. When researchers evaluate GHRP-2 acetate in biochemical assays, maintaining high purity and correct counterion stoichiometry is critical to ensuring baseline reproducibility without TFA-induced cell culture toxicity. Its chemical structure has a molecular weight of approximately 817.9 g/mol (free base), functioning as a potent synthetic ligand for targeted secretagogue receptor research.
In preclinical pharmacodynamics, GHRP-2 acetate acts as a potent agonist at the ghrelin receptor, formally known as the growth hormone secretagogue receptor subtype 1a (GHS-R1a). GHS-R1a is a seven-transmembrane G-protein-coupled receptor (GPCR) predominantly expressed on somatotroph cells in the anterior pituitary gland, as well as in specific hypothalamic nuclei.
Binding of GHRP-2 acetate to GHS-R1a activates the Gq/11 intracellular signaling pathway. This binding triggers the activation of phospholipase C (PLC), which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 binds to receptors on the endoplasmic reticulum, prompting a rapid influx of intracellular calcium ([Ca2+]i). Concurrently, DAG activates protein kinase C (PKC). This dual cascade drives the exocytosis of stored growth hormone granules from pituitary somatotrophs, establishing GHRP-2 as a foundational compound in growth hormone secretagogue research.
Preclinical investigations utilizing primary pituitary cell cultures and rodent models demonstrate that GHRP-2 acetate induces dose-dependent secretion of growth hormone. Unlike endogenous growth hormone-releasing hormone (GHRH), which operates via the adenylate cyclase/cAMP signaling pathway, GHRP-2 utilizes the GHS-R1a calcium-dependent pathway. Studies suggest that co-administration of GHRH and GHS-R1a agonists produces a synergistic GH release response in vitro, indicating distinct yet complementary cellular mechanisms.
Beyond pituitary somatotroph signaling, research models have evaluated GHRP-2 acetate for its central nervous system effects. Because GHS-R1a receptors are populated throughout the arcuate nucleus of the hypothalamus, preclinical administration of GHRP-2 acetate has been shown to stimulate neuropeptide Y (NPY) neurons. In rodent studies, this mechanism is observed to influence ghrelin-mediated orexigenic pathways, making the compound a valuable tool for studying energy balance, food intake regulation, and metabolic homeostasis in animal models.
When designing comparative secretagogue protocols, researchers frequently analyze GHRP-2 acetate alongside other synthetic ghrelin mimetics within the same chemical class. The choice of peptide significantly alters signal magnitude, receptor selectivity, and secondary endocrine output in experimental settings.
In preclinical literature, GHRP-2 acetate demonstrates higher binding potency for GHS-R1a compared to GHRP-6, yielding a larger amplitude of peak growth hormone release. However, GHRP-2 exhibits moderate secondary stimulation of adrenocorticotropic hormone (ACTH), cortisol, and prolactin in cellular assays, whereas Ipamorelin is recognized for its high selectivity, producing minimal impact on baseline cortisol or prolactin levels. Conversely, Hexarelin exhibits the highest absolute GH response amplitude among first-generation secretagogues but induces rapid receptor desensitization (tachyphylaxis) upon repeated exposure. Understanding these nuanced pharmacodynamic differences allows researchers to select the precise agonist for their laboratory requirements.
Evaluating research outcomes requires strict batch-to-batch consistency and high chemical purity. Synthetic peptides produced via solid-phase peptide synthesis (SPPS) can retain trace impurities, including deletion sequences, truncated peptides, and residual organic solvents. PX1 Research enforces stringent quality control measures to ensure that every lot of GHRP-2 acetate meets rigorous scientific criteria.
To verify analytical purity, every batch undergoes double analytical testing utilizing Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS). RP-HPLC quantifies chemical purity, ensuring a minimum standard of >99%, while ESI-MS verifies precise identity by matching theoretical molecular mass against observed spectra. Institutions can access lot-specific Certificates of Analysis (COA) directly through our verified laboratory portal.
In cell culture assays and live animal research models, bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative cell walls—present a severe confounding variable. Endotoxin contamination can trigger non-specific inflammatory signaling, upregulate tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), alter baseline cellular viability, and skew secretagogue release data.
PX1 Research integrates rigorous purification and Limulus Amebocyte Lysate (LAL) testing protocols for all synthesized compounds. Our GHRP-2 acetate lots are processed in GMP-compliant facilities and tested by ISO 17025 accredited analytical laboratories in the USA to verify endotoxin levels below 0.01 EU/mg. Protecting research integrity by eliminating bio-burden contaminants ensures reliable, reproducible data across primary pituitary and neuronal cell lines.
Proper reconstitution techniques are required to maintain peptide structural integrity and prevent physical degradation such as aggregation or precipitation. GHRP-2 acetate is supplied as a lyophilized (freeze-dried) cake or powder under vacuum sealing.
For laboratory preparation, researchers should allow the vial to reach room temperature before reconstitution to prevent moisture condensation. Reconstitution should be performed using sterile 0.9% Sodium Chloride, sterile Water for Injection, or Bacteriostatic Water (0.9% benzyl alcohol) depending on the assay design. Diluent should be directed down the glass wall of the vial rather than sprayed directly onto the lyophilized pellet. Gentle swirling or inversion is recommended to dissolve the peptide; vigorous vortexing or mechanical agitation must be avoided as high shear forces can denature delicate peptide chains.
Lyophilized GHRP-2 acetate maintains long-term chemical stability when stored in climate-controlled laboratory environments. For extended storage exceeding 30 days, lyophilized vials should be kept desiccated at -20°C or -80°C, protected from light exposure to prevent oxidative degradation of tryptophan residues within the sequence.
Once reconstituted into aqueous solution, the peptide exhibits reduced long-term stability due to hydrolysis pathways. Reconstituted solutions should be stored at 2°C to 8°C and evaluated within 21 to 30 days. To avoid repeated freeze-thaw cycles—which degrade peptide backbones through ice crystal formation—investigators should aliquot reconstituted solutions into single-use microcentrifuge tubes prior to deep freezing.
Academic laboratories, CROs, and institutional researchers require reliable sourcing pipelines with transparent documentation. PX1 Research manufactures research compounds within the USA, fulfilling orders from logistics hubs located in California and Arizona. Orders placed Monday through Friday before cut-off times qualify for same-day dispatch to prevent logistics delays.
Principal investigators and lab procurement officers can explore our complete catalog of research peptides or set up institutional ordering through a dedicated wholesale account. Detailed analytical data, safety data sheets (SDS), and comprehensive research documentation are available across our entire PX1 Research library to support institutional compliance and experimental rigor.
What is the primary mechanism of action for GHRP-2 acetate in research models?
GHRP-2 acetate acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a). Upon binding, it stimulates the Gq/11-phospholipase C signaling pathway, inducing an intracellular calcium influx that triggers growth hormone release from anterior pituitary somatotrophs.
How does GHRP-2 acetate differ from GHRP-6?
GHRP-2 acetate exhibits higher binding affinity and functional potency at GHS-R1a compared to GHRP-6, resulting in a higher peak release of growth hormone in preclinical models. However, GHRP-2 induces mild secondary release of ACTH and prolactin, whereas GHRP-6 has a stronger effect on hypothalamic appetite pathways.
What purity levels are guaranteed for PX1 Research GHRP-2 acetate?
Every lot of GHRP-2 acetate supplied by PX1 Research is verified at ≥99% purity using Reverse-Phase HPLC and verified for exact mass identity using ESI-Mass Spectrometry by an independent ISO 17025 accredited laboratory.
Why is the acetate salt form preferred over TFA for laboratory research?
The acetate counterion provides improved solubility and bio-compatibility in cell culture and preclinical assays. High residual trifluoroacetate (TFA) can exert cytotoxic effects on cultured cells and interfere with baseline metabolic measurements.
What are the recommended storage temperatures for lyophilized and reconstituted GHRP-2 acetate?
Lyophilized GHRP-2 acetate should be stored at -20°C or -80°C for long-term stability. Once reconstituted in sterile aqueous diluent, the liquid solution should be kept at 2°C to 8°C and used within 30 days, or aliquoted and frozen to prevent freeze-thaw degradation.
What diluent should be used to reconstitute GHRP-2 acetate for in vitro assays?
Researchers typically use sterile 0.9% Sodium Chloride, sterile Water for Injection, or Bacteriostatic Water (0.9% benzyl alcohol) for reconstitution. The choice depends on whether the assay requires single-use sterile conditions or multi-dose sampling over several days.
How does PX1 Research test for endotoxin levels in peptide lots?
PX1 Research conducts Chromogenic Limulus Amebocyte Lysate (LAL) testing on every lot to verify that bacterial endotoxin levels remain strictly under 0.01 EU/mg, protecting cell cultures and animal models from inflammatory artifacts.
Can GHRP-2 acetate be evaluated in synergy with GHRH analogues?
Yes, preclinical studies frequently investigate GHRP-2 acetate in combination with GHRH analogues such as Sermorelin or CJC-1295. Because GHRH operates via cAMP and GHRP-2 operates via intracellular calcium pathways, co-administration exhibits synergistic GH secretion dynamics in laboratory models.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.